Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Inherit Metab Dis. 2001 Dec;24(8):824-32.

Outcome of tyrosinaemia type III.

Author information

  • 1Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, London, UK.

Abstract

Tyrosinaemia type III is a rare disorder caused by a deficiency of 4-hydroxyphenylpyruvate dioxygenase, the second enzyme in the catabolic pathway of tyrosine. The majority of the nine previously reported patients have presented with neurological symptoms after the neonatal period, while others detected by neonatal screening have been asymptomatic. All have had normal liver and renal function and none has skin or eye abnormalities. A further four patients with tyrosinaemia type III are described. It is not clear whether a strict low tyrosine diet alters the natural history of tyrosinaemia type III, although there remains a suspicion that treatment may be important, at least in infancy.

PMID:
11916315
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk